← Eichor
Condition: Childhood Ependymoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Childhood Ependymoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma
Phase 2/Phase 3 · 40 location(s) · Centre Leon Berard · NCT02265770International HIT-MED Registry (I-HIT-MED)
Phase N/A · 57 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT02417324Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Phase 1 · 1 location(s) · Children's National Research Institute · NCT06193759Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Phase 1 · 1 location(s) · Florida International University · NCT05857969Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Gliom
Phase 1 · 1 location(s) · Seattle Children's Hospital · NCT04185038Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
NA · 8 location(s) · University of California, San Francisco · NCT05057702Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents
Phase N/A · 1 location(s) · Institut Claudius Regaud · NCT05151718HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Phase 1 · 3 location(s) · M.D. Anderson Cancer Center · NCT03911388Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Phase 1 · 1 location(s) · Theodore S. Johnson · NCT05106296
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.